...
首页> 外文期刊>CNS & neurological disorders drug targets >Chalcone Derivatives Activate and Desensitize the Transient Receptor Potential Ankyrin 1 Cation Channel, Subfamily A, Member 1 TRPA1 Ion Channel: Structure-Activity Relationships in vitro and Anti-Nociceptive and Anti-inflammatory Activity in vivo
【24h】

Chalcone Derivatives Activate and Desensitize the Transient Receptor Potential Ankyrin 1 Cation Channel, Subfamily A, Member 1 TRPA1 Ion Channel: Structure-Activity Relationships in vitro and Anti-Nociceptive and Anti-inflammatory Activity in vivo

机译:查尔酮衍生物激活和脱敏瞬态潜在的锚蛋白1阳离子通道,亚家族A,成员1 TRPA1离子通道:体外的结构活性关系和体内的抗伤害和抗炎活性。

获取原文
获取原文并翻译 | 示例

摘要

Eleven compounds belonging to the chalcone family were tested for their ability to activate and subsequently desensitize the rat transient receptor potential ankyrin 1 cation channel, subfamily A, member 1 (TRPA1) in a heterologous expression system. Four of the tested compounds were more potent than the TRPA1 agonist mustard oil, and showed also a strong desensitizing effect. Some chalcone compounds were not pungent in the eye-wiping assay and quite remarkably inhibited in a long-lasting and dose-dependent manner the pain response in the formalin test. Chalcones can be considered as novel candidates for the development of anti-hyperalgesic preparations based on TRPA1 desensitization.
机译:测试了属于查尔酮家族的11种化合物在异源表达系统中激活和随后使大鼠瞬时受体潜在锚蛋白1阳离子通道亚家族A成员1(TRPA1)脱敏的能力。测试的化合物中有四种比TRPA1激动剂芥末油更有效,并且还显示出强大的脱敏作用。一些查尔酮化合物在擦眼试验中没有刺激性,并且以长效且剂量依赖性的方式非常明显地抑制了福尔马林试验中的疼痛反应。可以将Chalcones视为开发基于TRPA1脱敏的抗痛觉过敏制剂的新型候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号